A Study of GDC-0449 (Hedgehog Pathway Inhibitor) As Maintenance Therapy in Patients With Ovarian Cancer in a Second or Third Complete Remission

This study is currently recruiting participants.

Study NCT00739661 Information provided by Genentech

First Received: August 21, 2008 Last Updated: September 30, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	January 2012 (Final data collection date for primary outcome measure)